Liaoning Chengda Biotechnology Co (SHSE:688739) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Liaoning Chengda Biotechnology Co EBITDA Margin % Related Terms
Liaoning Chengda Biotechnology Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co EBITDA Margin % Chart
SHSE:688739 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Biotechnology Co EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Biotechnology Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co (SHSE:688739) has a EBITDA Margin % of 0.49% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Liaoning Chengda Biotechnology Co and its competitors. This is 99% below median its historical median of 53.42. Over the past decade, Liaoning Chengda Biotechnology Co's EBITDA Margin % has ranged from 7.05 to 62.88. According to the industry distribution chart, Liaoning Chengda Biotechnology Co ranks #261 out of 936 companies in the Biotechnology industry, placing it in the top 27.9%.
Is Liaoning Chengda Biotechnology Co's EBITDA Margin % too high?
Liaoning Chengda Biotechnology Co's current EBITDA Margin % of 0.49% is 99% below median its 10-year median of 53.42. Over the past 10 years, this metric has ranged from a low of 7.05 to a high of 62.88. Based on the distribution chart, Liaoning Chengda Biotechnology Co ranks #261 out of 936 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Liaoning Chengda Biotechnology Co ranks #261 out of 936 companies for EBITDA Margin %. This puts Liaoning Chengda Biotechnology Co in the upper half of its industry. Historically, Liaoning Chengda Biotechnology Co's own EBITDA Margin % has ranged from 7.05 to 62.88 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Liaoning Chengda Biotechnology Co and its competitors. Liaoning Chengda Biotechnology Co's current EBITDA Margin % is 0.49%, which is 99% below median its own 10-year median of 53.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.14, compared to a current price of ¥19.65 — trading 11.2% below its estimated fair value. The current EBITDA Margin % is 0.49%, which is 99% below median its 10-year median of 53.42. Liaoning Chengda Biotechnology Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current EBITDA Margin % is 0.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued.
The current stock price of ¥19.65 is trading 11.2% below its estimated GF Value™ of ¥22.14.
GuruFocus considers Liaoning Chengda Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688739:
EBITDA Margin %: 0.49% (99% below median its 10-year median of 53.42)
GF Value™: ¥22.14 vs. price of ¥19.65 (11.2% below fair value)
No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Biotechnology Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688739 has been successfully added to your 
